BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 30270343)

  • 1. Altered DNA Methylation Sites in Peripheral Blood Leukocytes from Patients with Simple Steatosis and Nonalcoholic Steatohepatitis (NASH).
    Wu J; Zhang R; Shen F; Yang R; Zhou D; Cao H; Chen G; Pan Q; Fan J
    Med Sci Monit; 2018 Oct; 24():6946-6967. PubMed ID: 30270343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide analysis of DNA methylation in human peripheral leukocytes identifies potential biomarkers of nonalcoholic fatty liver disease.
    Zhang RN; Pan Q; Zheng RD; Mi YQ; Shen F; Zhou D; Chen GY; Zhu CY; Fan JG
    Int J Mol Med; 2018 Jul; 42(1):443-452. PubMed ID: 29568887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenome-Wide Association Study Identifies Methylation Sites Associated With Liver Enzymes and Hepatic Steatosis.
    Nano J; Ghanbari M; Wang W; de Vries PS; Dhana K; Muka T; Uitterlinden AG; van Meurs JBJ; Hofman A; ; Franco OH; Pan Q; Murad SD; Dehghan A
    Gastroenterology; 2017 Oct; 153(4):1096-1106.e2. PubMed ID: 28624579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease.
    Murphy SK; Yang H; Moylan CA; Pang H; Dellinger A; Abdelmalek MF; Garrett ME; Ashley-Koch A; Suzuki A; Tillmann HL; Hauser MA; Diehl AM
    Gastroenterology; 2013 Nov; 145(5):1076-87. PubMed ID: 23916847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis.
    Alonso C; Fernández-Ramos D; Varela-Rey M; Martínez-Arranz I; Navasa N; Van Liempd SM; Lavín Trueba JL; Mayo R; Ilisso CP; de Juan VG; Iruarrizaga-Lejarreta M; delaCruz-Villar L; Mincholé I; Robinson A; Crespo J; Martín-Duce A; Romero-Gómez M; Sann H; Platon J; Van Eyk J; Aspichueta P; Noureddin M; Falcón-Pérez JM; Anguita J; Aransay AM; Martínez-Chantar ML; Lu SC; Mato JM
    Gastroenterology; 2017 May; 152(6):1449-1461.e7. PubMed ID: 28132890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic Alanine Differentiates Nonalcoholic Steatohepatitis From Simple Steatosis in Humans and Mice: A Proton MR Spectroscopy Study With Long Echo Time.
    Kim TH; Jun HY; Kim KJ; Lee YH; Lee MS; Choi KH; Yun KJ; Jeong YY; Jun CH; Cho EY; Yoon KH
    J Magn Reson Imaging; 2017 Nov; 46(5):1298-1310. PubMed ID: 28225569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma phospholipids and fatty acid composition differ between liver biopsy-proven nonalcoholic fatty liver disease and healthy subjects.
    Ma DW; Arendt BM; Hillyer LM; Fung SK; McGilvray I; Guindi M; Allard JP
    Nutr Diabetes; 2016 Jul; 6(7):e220. PubMed ID: 27428872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Simple Index for Nonalcoholic Steatohepatitis-HUFA-Based on Routinely Performed Blood Tests.
    Culafic M; Vezmar Kovacevic S; Dopsaj V; Stulic M; Vlaisavljevic Z; Miljkovic B; Culafic D
    Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31163711
    [No Abstract]   [Full Text] [Related]  

  • 9. Association between endotoxemia and histological features of nonalcoholic fatty liver disease.
    Kitabatake H; Tanaka N; Fujimori N; Komatsu M; Okubo A; Kakegawa K; Kimura T; Sugiura A; Yamazaki T; Shibata S; Ichikawa Y; Joshita S; Umemura T; Matsumoto A; Koinuma M; Sano K; Aoyama T; Tanaka E
    World J Gastroenterol; 2017 Jan; 23(4):712-722. PubMed ID: 28216979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease.
    Pirola CJ; Gianotti TF; Burgueño AL; Rey-Funes M; Loidl CF; Mallardi P; Martino JS; Castaño GO; Sookoian S
    Gut; 2013 Sep; 62(9):1356-63. PubMed ID: 22879518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease.
    Ozturk O; Colak Y; Senates E; Yilmaz Y; Ulasoglu C; Doganay L; Ozkanli S; Oltulu YM; Coskunpinar E; Tuncer I
    World J Gastroenterol; 2015 Jul; 21(26):8096-102. PubMed ID: 26185381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease.
    Coulon S; Francque S; Colle I; Verrijken A; Blomme B; Heindryckx F; De Munter S; Prawitt J; Caron S; Staels B; Van Vlierberghe H; Van Gaal L; Geerts A
    Cytokine; 2012 Aug; 59(2):442-9. PubMed ID: 22658783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA Methylation in Nonalcoholic Fatty Liver Disease.
    Hyun J; Jung Y
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Pentraxin 3 Differentiates Nonalcoholic Steatohepatitis (NASH) from Non-NASH.
    Boga S; Koksal AR; Alkim H; Yilmaz Ozguven MB; Bayram M; Ergun M; Sisman G; Tekin Neijmann S; Alkim C
    Metab Syndr Relat Disord; 2015 Nov; 13(9):393-9. PubMed ID: 26367098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketone body production is differentially altered in steatosis and non-alcoholic steatohepatitis in obese humans.
    Männistö VT; Simonen M; Hyysalo J; Soininen P; Kangas AJ; Kaminska D; Matte AK; Venesmaa S; Käkelä P; Kärjä V; Arola J; Gylling H; Cederberg H; Kuusisto J; Laakso M; Yki-Järvinen H; Ala-Korpela M; Pihlajamäki J
    Liver Int; 2015 Jul; 35(7):1853-61. PubMed ID: 25533197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Nonalcoholic Fatty Liver Disease Via a Novel Panel of Serum Adipokines.
    Jamali R; Arj A; Razavizade M; Aarabi MH
    Medicine (Baltimore); 2016 Feb; 95(5):e2630. PubMed ID: 26844476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation signatures reflect aging in patients with nonalcoholic steatohepatitis.
    Loomba R; Gindin Y; Jiang Z; Lawitz E; Caldwell S; Djedjos CS; Xu R; Chung C; Myers RP; Subramanian GM; Goodman Z; Charlton M; Afdhal NH; Diehl AM
    JCI Insight; 2018 Jan; 3(2):. PubMed ID: 29367468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human liver epigenetic alterations in non-alcoholic steatohepatitis are related to insulin action.
    de Mello VD; Matte A; Perfilyev A; Männistö V; Rönn T; Nilsson E; Käkelä P; Ling C; Pihlajamäki J
    Epigenetics; 2017 Apr; 12(4):287-295. PubMed ID: 28277977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-genome DNA methylation and gene expression profiling in the livers of mice with nonalcoholic steatohepatitis.
    Bi H; Zhou B; Yang J; Lu Y; Mao F; Song Y
    Life Sci; 2023 Sep; 329():121951. PubMed ID: 37473799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential DNA methylation of steatosis and non-alcoholic fatty liver disease in adolescence.
    Melton PE; Burton MA; Lillycrop KA; Godfrey KM; Rauschert S; Anderson D; Burdge GC; Mori TA; Beilin LJ; Ayonrinde OT; Craig JM; Olynyk JK; Holbrook JD; Pennell CE; Oddy WH; Moses EK; Adams LA; Huang RC
    Hepatol Int; 2023 Jun; 17(3):584-594. PubMed ID: 36737504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.